FOR US HCPS ONLY
FULL PRESCRIBING INFORMATION 

Power combined

90% complete response for AKYNZEO® (n=135) during the overall phase compared to 77% for oral palonosetron (n=136) (p=0.003)1,2
  • An oral combination of netupitant and palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV)1
References: 1. AKYNZEO® (netupitant/palonosetron) capsules. Full Prescribing Information. 2. Hesketh P, Rossi G, Rizzi G, et al. Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study. Ann Oncol. 2014;25(7):1340-1346.